News

News from Partners
Jornal da USP: Study on gamma-delta T cell therapy wins award from the Instituto do Câncer do Estado de São Paulo
This content is in Portuguese.
4 de novembro de 2024

C2PO News
Hemocentro de Ribeirão Preto publishes the lecture “CAR-NK Cell Immunotherapy: A Ribeirão Preto Initiative”
The lecture (in Portuguese) is presented by Dr. Virginia Picanço e Castro and is part of the Hemocentro de Ribeirão Preto’s series Inside Research.
1 de novembro de 2024

News from Partners
Jornal da USP: Students combine communication and technology to assist bladder cancer patients
This content is in Portuguese.
31 de outubro de 2024

News from Partners
Jornal da USP: Physical conditioning can positively influence lung cancer treatment.
This content is in Portuguese.
30 de outubro de 2024

C2PO News
ICESP/FMUSP researcher launches new version of app developed to map differentially correlated genes
New version of the application developed by researcher Alexis Germán Murillo Carrasco offers improvements and makes usage more user-friendly.
30 de outubro de 2024

News from Partners
Jornal da USP: Researchers need nurses and doctors to evaluate a platform that identifies high-risk cancer patients
This content is in Portuguese.
29 de outubro de 2024

News from Partners
Jornal da USP: Misinformation in online advertising is the newest challenge in healthcare
This content is in Portuguese.
29 de outubro de 2024

News from Partners
Jornal da USP: Groundbreaking study reveals link between zinc accumulation and muscle atrophy in ICU patients
This content is in Portuguese.
25 de outubro de 2024

News from Partners
Jornal da USP: Genomic medicine takes into account the patient’s characteristics to treat the disease
This content is in Portuguese.
24 de outubro de 2024

News from Partners
Jornal da USP: USP laboratory in São Carlos develops technologies for digital mammography diagnosis
This content is in Portuguese.
24 de outubro de 2024

C2PO News
Nucleic Acids and Nanobiosystems in Cancer Theranostics event featured lectures by experts and space for young researchers
The event lasted four days, involved 180 participants from 15 countries, and offered various activities that promoted learning about new technologies for cancer diagnosis and treatment.
23 de outubro de 2024
